Table 1.
PN (n=82) | Active Surveillance (n=32) | p | |||
---|---|---|---|---|---|
N/Median | %/IQR | N/Median | %/IQR | ||
Age (years) | 65 | 59–71 | 72 | 64–76 | <0.001 |
Max Tumor Diameter (cm) | 2.8 | 2.5–3.3 | 2.9 | 2.6–3.4 | 0.634 |
Baseline Cr | 0.9 | 0.8–1.0 | 1 | 0.9–1.3 | 0.0154 |
Baseline eGFR | 82 | 73–94 | 71 | 43–84 | <0.001 |
BMI | 28 | 25–33 | 29 | 26–34 | 0.621 |
Gender | 0.51 | ||||
Female | 23 | 28% | 11 | 34% | |
Male | 59 | 72% | 21 | 66% | |
Race | 1.00 | ||||
White | 77 | 94% | 31 | 97% | |
Non-white | 5 | 6.1% | 1 | 3.10% | |
Hypertension | 0.13 | ||||
No | 30 | 37% | 7 | 22% | |
Yes | 52 | 63% | 25 | 78% |